|86.40||-4.29 / -4.73%|
As of Aug 31
|83.45||-2.95 / -3.41%|
The 8 analysts offering 12-month price forecasts for Agios Pharmaceuticals Inc have a median target of 119.00, with a high estimate of 132.00 and a low estimate of 84.00. The median estimate represents a +37.73% increase from the last price of 86.40.
The current consensus among 10 polled investment analysts is to Hold stock in Agios Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.